------ 臺灣民生廣告 hk.oofof.com 關注民生.服務民生 低碳生活從民生廣告開始 嚴禁亂貼 亂畫 保護環境 保護資源 節約紙張 ----
Global 10-Deacetylbaccatin III market will reach 78 million US$ by the end of 2025
Published Date: 2018/11/7
Global 10-Deacetylbaccatin III Market Research Report 2018 studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
As new companies enter the market for finished paclitaxel, bulk demand will increase as competition forces down prices, the study notes, adding that, with the drug becoming more affordable, physicians are expected to prescribe it more freely. However, while demand may be rising, paclitaxel is derived from a natural resource, and its long-term availability is in question.
Yew trees are slow-growing, and the extraction process requires numerous trees to supply an adequate amount, it says. The possible scarcity of the product is spurring sales, especially to the research sector where large stocks are necessary for proper experimentation. However, the report notes that enterprising companies have found ways to circumvent this issue and increase supply.
With advances in technology, new and better ways of extracting paclitaxel have evolved, with plant cell culture techniques and genetic engineering also emerging as fruitful methods of enhancing production says F&S. These methods have resulted in ample and continuous supplies, which is expected to boost the quantities of bulk paclitaxel, and subsequently augment the revenues generated by finished products, the report adds.
The global 10-Deacetylbaccatin III market is valued at 58 million US$ in 2017 and will reach 78 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2018-2025.
Click to view the full report: https://www.qyresearch.com/index/detail/211422/global-10-deacetylbaccatin-iii-market
This article was first released by QYResearch, if reproduced, please indicate the source.
Media Contact: email@example.com
信息站點：新加坡臺灣>>只看發布地是 臺灣 的信息>>
詳細地址：Tianhe,Guangzhou, Guangdong Province, CN
Copyright 2008-2030 民生廣告網版權所有 南甯凡中商務有限公司 網站備案/許可證編號:桂ICP備11002991號
客戶服務郵箱： firstname.lastname@example.org (鄭重提醒: 交易請注意證件齊全,提高警惕，謹防上當！)